Emergence of a splenic CD81+ erythroblast subset triggered by leukemia potentiates disease progression (PRJCA025483)
Here, we observed an AML-induced CD81+ erythroblast subpopulation in AML mouse spleen, which enhances the AML cell amplification and ultimately leads to shortened lifespan of AML mice.